1. Home
  2. GDRX vs VOR Comparison

GDRX vs VOR Comparison

Compare GDRX & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoodRx Holdings Inc.

GDRX

GoodRx Holdings Inc.

N/A

Current Price

$2.93

Market Cap

1.2B

Sector

Technology

ML Signal

N/A

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

N/A

Current Price

$19.15

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GDRX
VOR
Founded
2011
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
GDRX
VOR
Price
$2.93
$19.15
Analyst Decision
Hold
Strong Buy
Analyst Count
14
10
Target Price
$3.95
★ $39.00
AVG Volume (30 Days)
★ 1.1M
636.5K
Earning Date
12-01-2026
10-30-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 125.00
N/A
EPS
★ 0.03
N/A
Revenue
★ $796,853,000.00
N/A
Revenue This Year
$0.20
N/A
Revenue Next Year
$4.73
N/A
P/E Ratio
$100.50
★ N/A
Revenue Growth
★ 0.57
N/A
52 Week Low
$1.77
$7.21
52 Week High
$3.89
$26.00

Technical Indicators

Market Signals
Indicator
GDRX
VOR
Relative Strength Index (RSI) 31.40 48.50
Support Level $2.83 $17.62
Resistance Level $3.12 $20.11
Average True Range (ATR) 0.19 1.29
MACD -0.07 -0.09
Stochastic Oscillator 0.57 44.48

Price Performance

Historical Comparison
GDRX
VOR

About GDRX GoodRx Holdings Inc.

GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Share on Social Networks: